Norbert Gerdes
Overview
Explore the profile of Norbert Gerdes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
2562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lang A, Oehler D, Benkhoff M, Reinders Y, Barcik M, Shahrjerdi K, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457679
Background/objectives: Acute myocardial infarction (AMI), characterized by irreversible heart muscle damage and impaired cardiac function caused by myocardial ischemia, is a leading cause of global mortality. The damage associated with...
2.
Ahrazoglu T, Kluczny J, Kleimann P, Irschfeld L, Nienhaus F, Bonner F, et al.
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456184
Human monocytes can be subdivided into phenotypically and functionally different classical, intermediate and non-classical monocytes according to the cell surface expression of CD14 and CD16. A precise identification and characterisation...
3.
Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P, et al.
Circulation
. 2024 Oct;
151(4):333-347.
PMID: 39429140
Background: Aortic valve disease (AVD) is associated with high mortality and morbidity. To date, there is no pharmacological therapy available to prevent AVD progression. Because valve calcification is the hallmark...
4.
Duplessis A, Elster C, Becher S, Engel C, Lang A, Kaldirim M, et al.
Cells
. 2024 Oct;
13(19.
PMID: 39404396
Determination of infarct and scar size following myocardial infarction (MI) is commonly used to evaluate the efficacy of potential cardioprotective treatments in animal models. However, histological methods to determine morphological...
5.
Geissen S, Braumann S, Adler J, Nettersheim F, Mehrkens D, Hof A, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2269-2281.
PMID: 39212229
Aims: Non-ischaemic cardiomyopathy (NICMP), an incurable disease terminating in systolic heart failure (heart failure with reduced ejection fraction [HFrEF]), causes immune activation, however anti-inflammatory treatment strategies so far have failed...
6.
Gerdes N, Klingenberg R
Front Cardiovasc Med
. 2024 Aug;
11:1448664.
PMID: 39211769
Here, we provide a concise overview of recent developments in the identification of immunogenic epitopes in human apolipoprotein B-100 for immunization against atherosclerotic cardiovascular disease. Major steps forward toward a...
7.
Donner L, Kruger I, Pfeiler S, Gerdes N, Schaller M, Kelm M, et al.
Mol Cell Neurosci
. 2024 Jul;
130:103952.
PMID: 39002827
Alzheimer's disease (AD) is the most common form of dementia and characterized by extracellular amyloid-β (Aβ) plaques, intracellular neurofibrillary tau tangles and neurodegeneration. Over 80 % of AD patients also...
8.
Quast C, Bonner F, Polzin A, Veulemans V, Chennupati R, Gyamfi Poku I, et al.
Circulation
. 2024 Jun;
150(12):952-965.
PMID: 38836358
Background: Whether aortic valve stenosis (AS) can adversely affect systemic endothelial function independently of standard modifiable cardiovascular risk factors is unknown. Methods: We therefore investigated endothelial and cardiac function in...
9.
Binneboessel S, Gerdes N, Baertschi M, Kaya S, Geerling G, Kelm M, et al.
Arterioscler Thromb Vasc Biol
. 2024 May;
44(7):1716-1718.
PMID: 38721708
No abstract available.
10.
Theissen L, Schroeter C, Huntemann N, Rauber S, Dobelmann V, Cengiz D, et al.
Cells
. 2024 Mar;
13(6.
PMID: 38534352
Myasthenia gravis (MG) is a prototypical autoimmune disease of the neuromuscular junction (NMJ). The study of the underlying pathophysiology has provided novel insights into the interplay of autoantibodies and complement-mediated...